Burkin D J, Wallace G Q, Nicol K J, Kaufman D J, Kaufman S J
Department of Cell and Structural Biology, University of Illinois, Urbana, Illinois 61801, USA.
J Cell Biol. 2001 Mar 19;152(6):1207-18. doi: 10.1083/jcb.152.6.1207.
Muscle fibers attach to laminin in the basal lamina using two distinct mechanisms: the dystrophin glycoprotein complex and the alpha 7 beta 1 integrin. Defects in these linkage systems result in Duchenne muscular dystrophy (DMD), alpha 2 laminin congenital muscular dystrophy, sarcoglycan-related muscular dystrophy, and alpha 7 integrin congenital muscular dystrophy. Therefore, the molecular continuity between the extracellular matrix and cell cytoskeleton is essential for the structural and functional integrity of skeletal muscle. To test whether the alpha 7 beta 1 integrin can compensate for the absence of dystrophin, we expressed the rat alpha 7 chain in mdx/utr(-/-) mice that lack both dystrophin and utrophin. These mice develop a severe muscular dystrophy highly akin to that in DMD, and they also die prematurely. Using the muscle creatine kinase promoter, expression of the alpha 7BX2 integrin chain was increased 2.0-2.3-fold in mdx/utr(-/-) mice. Concomitant with the increase in the alpha 7 chain, its heterodimeric partner, beta 1D, was also increased in the transgenic animals. Transgenic expression of the alpha 7BX2 chain in the mdx/utr(-/-) mice extended their longevity by threefold, reduced kyphosis and the development of muscle disease, and maintained mobility and the structure of the neuromuscular junction. Thus, bolstering alpha 7 beta 1 integrin-mediated association of muscle cells with the extracellular matrix alleviates many of the symptoms of disease observed in mdx/utr(-/-) mice and compensates for the absence of the dystrophin- and utrophin-mediated linkage systems. This suggests that enhanced expression of the alpha 7 beta 1 integrin may provide a novel approach to treat DMD and other muscle diseases that arise due to defects in the dystrophin glycoprotein complex. A video that contrasts kyphosis, gait, joint contractures, and mobility in mdx/utr(-/-) and alpha 7BX2-mdx/utr(-/-) mice can be accessed at http://www.jcb.org/cgi/content/full/152/6/1207.
肌营养不良蛋白糖蛋白复合体和α7β1整合素。这些连接系统的缺陷会导致杜氏肌营养不良症(DMD)、α2层粘连蛋白先天性肌营养不良症、肌聚糖相关肌营养不良症以及α7整合素先天性肌营养不良症。因此,细胞外基质与细胞细胞骨架之间的分子连续性对于骨骼肌的结构和功能完整性至关重要。为了测试α7β1整合素是否能够弥补肌营养不良蛋白的缺失,我们在同时缺乏肌营养不良蛋白和抗肌萎缩蛋白的mdx/utr(-/-)小鼠中表达大鼠α7链。这些小鼠会发展出一种严重的肌营养不良症,与DMD高度相似,并且它们也会过早死亡。利用肌肉肌酸激酶启动子,α7BX2整合素链在mdx/utr(-/-)小鼠中的表达增加了2.0 - 2.3倍。伴随着α7链的增加,其异二聚体伴侣β1D在转基因动物中也有所增加。α7BX2链在mdx/utr(-/-)小鼠中的转基因表达使它们的寿命延长了三倍,减少了脊柱后凸和肌肉疾病的发展,并维持了神经肌肉接头的活动能力和结构。因此,增强α7β1整合素介导的肌肉细胞与细胞外基质的结合可减轻mdx/utr(-/-)小鼠中观察到的许多疾病症状,并弥补肌营养不良蛋白和抗肌萎缩蛋白介导的连接系统的缺失。这表明增强α7β1整合素的表达可能为治疗DMD和其他由于肌营养不良蛋白糖蛋白复合体缺陷而引起的肌肉疾病提供一种新方法。可通过http://www.jcb.org/cgi/content/full/152/6/1207访问一段对比mdx/utr(-/-)和α7BX2 - mdx/utr(-/-)小鼠脊柱后凸、步态、关节挛缩和活动能力的视频。